Author

A.A. Abo Taleb

Observed names: A Taleb, A. Taleb, Ayoub Taleb

Institution: Hôpital Mustapha Pacha

Observed institutions: Institut Gustave Roussy, Bristol-Myers Squibb (United States), Bristol-Myers Squibb (France), Hôpital Mustapha Pacha, World Health Organization - Egypt, Institut de Recherche Pierre Fabre (France)

OpenAlex ID: A5111033445

Phase I pharmacokinetic profile and early clinical evaluation of the PAN-HER inhibitor BMS-599626

2005 · J. C. Soria, J. Cortes, et al. · Journal of Clinical Oncology · 7

Efficacy of Sofosbuvir/Daclatasvir in a Single Tablet for Treating Chronic Viral Hepatitis C

2023 · Nabil Debzi, Saadi Berkane, et al. · Journal of Clinical Pharmacy and Therapeutics · 3

A dose-finding and pharmacokinetic study of I.V. vinflunine in combination with doxorubicin as first line treatment of metastatic breast cancer.

2009 · J Machiels, P Chollet, et al. · Cancer Research · 1

Economic Evaluation of Lapatinib in Her-2-Positive Metastatic Breast Cancer Patients in Egypt

2014 · G. Elsisi, E. Mady, et al. · Value in Health

Works count: 4

Citation count: 11

H-index: 2

I10-index: